Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein

US Patent 10426819 · Granted Oct 1, 2019

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the p2020
Methods of modulating immune responses using BCMA polypeptide2019
Intra-amniotic administration of EDI200 for the treatment of ectodermal dysplasi2019
Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 prote2018
Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 prote2018
Anti-ectodysplasin antibodies2017
Anti-ectodysplasin antibodies2017
Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA)2017
Treatment of X-linked hypohidrotic ectodermal dysplasia with ectodysplasin A ago2015
Pharmaceutical composition comprising EDA-1 Fusion Protein2014
Methods of screening for a compound that inhibits the interaction between BAFF a2014
Preparation of isolated agonist anti-EDAR monoclonal antibodies2014